Telmisartan

Major Drug Quality Failures: Pan D, Shelcal, and Anti-Diabetes Medications Flagged by Indian Regulators

Recent quality tests conducted by India’s drug regulatory agency have revealed alarming failures in several widely-used medications, prompting concerns about patient safety and public health. The Central Drugs Standards Control Organisation (CDSCO) issued a “Not of Standard Quality (NSQ)” alert for August, highlighting over 50 drugs, including well-known treatments for...